Previous 10 | Next 10 |
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and Hikma Pharmaceuticals, a multi-national pharmaceutical company and leading licensing partner in the Middle East and North Africa (...
Sesen Bio's Vicineum has an upcoming catalyst. Yet, the stock is depressed, and the market cap is low. Sesen also has low cash runway. For further details see: Sesen Bio: A Look At Vicineum's Potential
4 Biotech Penny Stocks To Watch Right Now Penny stocks remain red hot this week as markets turn up the heat on bullish momentum. Aside from speculation on what government measures will be taken in 2021, traders are also digesting several big vaccine updates. Last week we got new...
Sesen Bio, Inc. (SESN) Q3 2020 Earnings Conference Call November 9, 2020 08:00 AM ET Company Participants Erin Clark - Vice President of Investor Relations Thomas Cannell - President and Chief Executive Officer Chad Myskiw - Strategic Planning, CMC Monica Forbes - Chief Financial Officer Conf...
The following slide deck was published by Sesen Bio, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Sesen Bio, Inc. 2020 Q3 - Results - Earnings Call Presentation
Sesen Bio, Inc. (SESN) Q3 2020 Earnings Conference Call November 9, 2020 7:50 A.M. ET Company Participants Erin Clark - Vice President of Investor Relations Thomas Cannell - President and Chief Executive Officer Chad Myskiw - Strategic Planning, CMC Monica Forbes - Chief Financial Officer Con...
Sesen Bio (SESN): Q3 GAAP EPS of -$0.19 misses by $0.11.Revenue of $11.24MPress Release For further details see: Sesen Bio EPS misses by $0.11
Manufacturing of Vicineum drug substance and drug product PPQ batches has been completed Emerging manufacturing data provides strong support for analytical comparability between clinical and commercial material On track to complete BLA submission to the FDA in December...
Biotech Penny Stocks to Watch In November 2020 Biotech penny stocks have been making some big headway in the market in the past six months. Following the advent of Covid, many investors began to hedge bets on biotech stocks for the future. While some stocks that are dealing with...
Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Company management will host a conference call on Monday, November 9, 2020 at 8:00 a.m. ET to review operating...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...